Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates, the company said in an announcement posted by the Food and Drug Administration on Nov. 20. The products are being recalled to the consumer level because of a potential lack of sterility assurance, including some products that were compounded by Greenwich Rx for another pharmacy, Clove Rx.

Those concerns arose following an inspection of the pharmacy by the FDA and Greenwich Rx's evaluation of the affected products, the company said. Use of a drug product intended to be sterile that is not sterile could result in serious infections, which may be life threatening. Greenwich Rx said it has not identified any evidence of contamination in the recalled products and is initiating the recall as a precautionary measure. To date, the company said, it has not received any reports of adverse events related to this recall.

The affected products were dispensed nationwide between Aug. 10, 2026, and Sept. 21, 2026. A list of affected products, lot numbers, and beyond-use dates is posted on the company's website at greenwichrx.org/news/general-recall-2026-11. Customers of Greenwich Rx and Clove Rx should compare the information on their medication labels with that list to confirm whether a medication is part of the recall, the announcement said.

This is not a recall of every compounded medicine in the United States, and the FDA posting does not itself name every lot in the body of the announcement. Readers who have a sterile compounded product from Greenwich Rx or Clove Rx need the lot list, not a guess from a headline.

Greenwich Rx is notifying its affected customers of the voluntary recall by mail. Customers who received medications through Clove Rx should review the affected product list even if they have not received a direct recall notification, the company said, and it encouraged those customers to contact Sedgwick if they have questions about whether a Clove Rx product is included.

Consumers and clinics that have a product being recalled should stop use of the product immediately and discard it, the company said. The announcement pointed to FDA information on safe disposal of unused medicines at FDA.gov/DrugDisposal.

Questions about the recall can be directed to Sedgwick at 888-243-5547 or [email protected], Monday through Friday between 8 a.m. and 5 p.m. Eastern time. Consumers should contact their physician or health care provider if they have experienced any problems that may be related to taking or using the recalled products. Adverse reactions or quality problems may also be reported to the FDA's MedWatch program online or by calling 1-800-332-1088 to request a form.

Media contacts listed in the announcement are Lauren Jennings and Don Williams of Glodow Nead Communications. The recall is being conducted with the knowledge of the FDA, the company said. The agency posted the announcement as a public service and said it does not endorse either the product or the company.